Browse by Audience
Skip to content
Papers of the Week
Bone marrow mesenchymal stem cells improve bone cancer pain by inhibiting p38MAPK phosphorylation and microglia activation.
Authors
Kan H, Huang J, Gui X, Tian W, Fan L, Chen X, Ding X, Chen L, Shen WAbstract
Bone cancer pain (BCP) is not adequately addressed by current treatment methods, making the exploration of effective management strategies a topic of significant interest. Bone marrow mesenchymal stem cells (BMSCs) seem to be a potential way for managing BCP, yet little is known about the mechanisms underlying the efficacy of this potential treatment.